Roche

Roche spins out Nimble Therapeutics to capitalize on peptide drug discovery, with $10M support from Telegraph Hill Partners
Endpoints
Tue, 04/30/19 - 05:35 pm
Roche
Nimble Therapeutics
peptide drug discovery
Pfizer Takes Top Spot in Pharma Market Cap for 2018, Analysis Shows
BioSpace
Sun, 04/28/19 - 12:28 pm
Pfizer
Roche
Sanofi's Eloctate, a Bioverativ buyout centerpiece, suffers on Roche's Hemlibra launch
Fierce Pharma
Fri, 04/26/19 - 07:39 pm
Sanofi
Bioverativ
M&A
diabetes
Eloctate
Roche
Hemlibra
Roche delays $4.3B Spark buyout — again — as FTC review drags on
Endpoints
Fri, 04/26/19 - 10:12 am
Roche
Spark Therapeutics
M&A
FTC
Roche throws in the towel on Tecentriq bladder, myeloma trials
Fierce Pharma
Fri, 04/19/19 - 06:16 pm
Roche
Tecentriq
bladder cancer
Multiple Myeloma
clinical trials
Roche's pharma business is booming, for now
BioPharma Dive
Wed, 04/17/19 - 12:27 pm
Roche
earnings
Hemlibra
The top 15 pharma companies by 2018 revenue
Fierce Pharma
Mon, 04/8/19 - 11:30 pm
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Big Pharma come together for better drug side effect detection
Pharma Times
Sun, 04/7/19 - 05:18 pm
side effects
adverse events
Pfizer
Roche
Takeda
Eli Lilly
Bristol-Myers Squibb
Gilead Sciences
Alexion
Celgene
International Working Group on Signal Detection and Management in Pharmacovigilance
pharmacovigilance
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Medical Devices and Diagnostics Industry
Sat, 04/6/19 - 01:47 pm
eye health
artificial intelligence
Roche
Genentech
diabetic macular edema
Roche must ask Spark shareholders once again to sell
Biopharma Dive
Wed, 04/3/19 - 12:23 pm
Roche
Spark Therapeutics
gene therapy
M&A
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
BioCentury
Mon, 04/1/19 - 09:32 pm
Roche
clinical trials
Ipatasertib
metastatic triple-negative breast cancer
AACR
Roche-backed Arch Oncology gets off $50M round for anti-CD47 cancer work
Fierce Biotech
Mon, 03/25/19 - 11:55 am
Arch Oncology
Roche
immuno-oncology
Roche Seeks Millions in Diabetes Test Strip Lawsuit
BioSpace
Thu, 03/21/19 - 06:46 pm
Roche
diabetes
Alliance Medical Products
Gene therapy progress spurs competition in biotech buyouts
Biopharma Dive
Tue, 03/19/19 - 11:41 pm
biotech
gene therapy
M&A
Biogen
Nightstar Therapeutics
Roche
Spark Therapeutics
Roche’s Tecentriq gains new US lung cancer indication
Pharmaforum
Tue, 03/19/19 - 11:41 am
Roche
Genentech
Tecentriq
FDA
extensive-stage small cell lung cancer
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Sat, 03/16/19 - 12:25 pm
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Sat, 03/16/19 - 12:18 pm
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid biosimiar competition?
Endpoints
Fri, 03/15/19 - 09:30 am
Roche
MabThera
Rituxan
Europe
biosimilars
Lilly's combo treatment meets main goal in lung cancer late-stage study
Yahoo/Reuters
Tue, 03/12/19 - 10:12 am
Eli Lilly
Cyramza
clinical trials
metastatic non-small cell lung cancer
Roche
erlotinib
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
First Word Pharma
Fri, 03/8/19 - 02:27 pm
Roche
Genentech
FDA
Tecentriq
triple negative breast cancer

Pages